Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraj Gupta

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Molecular Biology|April 23, 2025
CIWARS: A Web Server for Antibiotic Resistance Surveillance Using Longitudinal Metagenomic DataMuhit Islam Emon, Yat Fei Cheung, James Stoll, et al.
Environmental Science & Technology|June 27, 2022
Demonstrating a Comprehensive Wastewater-Based Surveillance Approach That Differentiates Globally Sourced ResistomesMaria Virginia Prieto Riquelme, Emily Garner, Suraj Gupta, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Molecular Biology|April 23, 2025
CIWARS: A Web Server for Antibiotic Resistance Surveillance Using Longitudinal Metagenomic DataMuhit Islam Emon, Yat Fei Cheung, James Stoll, et al.
Environmental Science & Technology|June 27, 2022
Demonstrating a Comprehensive Wastewater-Based Surveillance Approach That Differentiates Globally Sourced ResistomesMaria Virginia Prieto Riquelme, Emily Garner, Suraj Gupta, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Pageof 4